Takeda aims to become a company that grows together with its shareholders and other stakeholders while developing a strong identity as a good corporate citizen. Takeda has committed to strengthening information disclosure activities. Takeda is proactively striving for information disclosure, based on the Company policy targeting management transparency.
Latest Financial Results
FY 2011 Q3 Results
( February 1, 2012 )
→link to Nomura IR's website
Page Top
Latest Reports
2011 Annual Report
[Message and Interview] Yasuchika Hasegawa, President & CEO
“The 2011-2013 Mid-Range Plan”
Innovation
Shigenori Ohkawa, Ph.D., Chief Scientific Officer /
“The Shonan Research Center”
Culture
[Interview] Toyoji Yoshida, Chief Administration Officer
Growth
[Interview] Frank Morich, M.D., Ph.D., International Operations (Americas/Europe)
Corporate Activities and Achievements in Fiscal 2010
Contribution to Society through Pharmaceutical Business
[Interview] Haruhiko Hirate, International Operations (Asia)
Relationship with Our Stakeholders
Management Organization
Financial Section
2011 CSR Data Book
Culture
[Interview] Toyoji Yoshida, Chief Administration Officer
Organizational Governance
Human Rights
Labor Practices
The Environment
Fair Operating Practices
Consumer Issues
Community Involvement and Development
Page Top
IR Calendar February 1, 2012 Early May, 2012 Early May, 2012 Early June, 2012 Late June, 2012 Late June, 2012 Late June, 2012 Late July, 2012 Early September, 2012 Early November, 2012 Early November, 2012 Early December, 2012
Note : that the dates shown above are tentative plans and subject to change.
